HERNDON, Va., Oct. 13 /PRNewswire/ — Trianz
Business Solutions is pleased to announce that REGISTRAT-MAPI, a long
term client of Acceliant eClinical suite,
has agreed to serve as advisors in the development of the ePRO/mPRO
module for Acceliant. REGISTRAT-MAPI has utilized Acceliant since
2007, for many of their Late Phase studies. REGISTRAT-MAPI, using
their clinical experience and knowledge of the industry accumulated
conducting Late Phase studies, will advise Trianz in defining and
reviewing the ePRO module.
Stephen Webb, REGISTRAT-MAPI, President North America stated
that, “since the majority of our late phase studies include
collecting, analyzing and interpreting patient reported outcome
(PRO) data to demonstrate product effectiveness and evidence based
science, having these robust ePRO tools and web-based applications
significantly contribute to successful conduct of these
studies.”
Acceliant V6.1, released earlier this year, and V6.2 scheduled
for Q4 2010 release, already incorporates a number of functional
enhancements identified by REGISTRAT-MAPI based on their unique PRO
experience as the leading Global Late Phase CRO dedicated to ‘real
life’ clinical research. Trianz and REGISTRAT-MAPI greatly value
this mutually benefitted collaboration. The Acceliant ePRO module
seamlessly integrates with the Acceliant eClinical Suite to expand
the breadth of data collection channels and technology options.
Sri Manchala, President and CEO of Trianz, adds,
“Acceliant ePRO supports a rich set of features for patients to
register, enroll and complete the necessary forms. Data capture
applications include: Web, Smart Phones, Tablets, and IVRS.
Additionally, the ePRO module provides sites with patient pr
‘/>”/>
